Global In Vitro Fertilization Market By Offering(Devices and systems, Culture Media and Reagents, Equipment and Accessories) By Type(Convectional IVF, IVF with Intracytoplasmic Sperm Injection (ICSI)) By Procedure Type (Fresh Donor, Frozen Donor, Fresh Non donor, Frozen non donor) By End Users(Hospitals and clinics, Fertility Clinics, Commercial labs, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Industry Trends
In vitro fertilisation is referred to as IVF which is one of the more well-known applications of assisted reproductive technologies (ART). In order to help sperm fertilise an egg and to implant the fertilised egg in the uterus, in vitro fertilisation (IVF) uses a mix of medications and surgical techniques. Socio-demographic changes have led to an increase in the demand for in vitro fertilisation (IVF) and new technologies have made it easier to supply the procedure, changing how a sizable part of people reproduce, in addition to providing an overview of new technologies that have the potential to significantly boost IVF utilisation and decrease its cost. Globally, decreasing fertility rates is a result of women having better access to educational and employment opportunities as well as effective contraception. Fertility rates are now far lower below population replacement levels of 2100 births per 1000 women in numerous nations and almost all U.S. states. By using modern technologies, significant progress has already been made towards automating each of these discrete stages. However, the entire IVF process is still very manual. The completely new idea of an IVF lab on a chip has the potential to transform IVF by allowing nearly all of the steps to be automated in a single device. Up to 10% of all children may be conceived by IVF in the not too distant future in several regions of the world. It is critical that the general public and regulatory organisations participate in creating a framework for the ethical assessment of future technologies, given the rapid scientific and technological progress of IVF and reproductive genetics. Thus, these factors are poised to propel the growth of global in vitro fertilization market.
In terms of revenue, global in vitro fertilization market is projected to reach US$ 40.8 Bn by 2031, growing at a CAGR of 5.9% over the forecast period (2023 – 2031). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Offerings Outlook
Based on the offerings segments, the global in vitro fertilization market is segmented into devices and systems, culture media and reagents, equipment and accessories. Various devices and systems such as incubators, workstations, micromanipulators and lasers are widely used in IVF procedures. Leading market players are incorporating advanced technologies into these devices for better results and ease of the procedure. On the other hand IVF culture media has seen considerable progress in the development of culture media for ART and infertility treatment. For instance, it was studied that the type of culture media used in IVF can more than double the chance of producing healthy embryos and significantly affect chances of successful conception. Thus, these innovations is supporting the growth of the global in vitro fertilization market.
Procedure Type Outlook
Based on the procedure type, the global in vitro fertilization market is segmented into fresh donor, frozen donor, fresh non donor, frozen non donor. Frozen eggs segment is anticipated to be the fastest growing segment in the upcoming years. Using frozen eggs makes IVF much more convenient for patients, as the recipient and the egg donor do not have to have their cycles in sync and also be potentially less expensive, as eggs from a single donor can be shared more easily among several recipients. Frozen donor eggs are a realistic alternative for couples and single people who need the help of an egg donor to conceive, due to recent improvements in egg freezing procedures and frozen donor egg success rates. Thus with advancements in the storage of eggs and its process, the frozen eggs segment will help boost the global in vitro fertilization market.
Region Outlook
Based on the regions, North America had the highest share in the in vitro fertilization market in 2022. Fertility is a growing concern for Americans. According to reports, one in eight couples have trouble getting pregnant, and a third of Americans have either had fertility therapy themselves or know someone who has. In the last few years, the availability and affordability of IVF are directly related to its use. In fact, an increasing number of U.S. states are implementing a range of measures to stop the decline in fertility rates. These policies range from subsidised child care programmes to insurance coverage for fertility treatments that is legally required. Another new trend is that more well-known companies are choosing to pay for fertility benefits as part of their social missions and as a way to recruit and keep staff. When all of the policies that support better insurance coverage are combined, patients' costs for IVF will decrease and its use will rise. Thus with the above factors the in vitro fertilization market in North A7merica is expected to boost during the forecast period.
Competitive Landscape
The report provides both, qualitative and quantitative research of global in vitro fertilization market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global in vitro fertilization market are:
- A CooperSurgical Fertility Company
- Boston IVF
- Cook
- Esco Micro Pte. Ltd.
- Fujifilm Irvine Scientific
- Genea Biomedx
- IVFtech ApS
- Kitazato Corporation
- OvaScience
- Thermo Fisher Scientific
- Vitrolife AB
- Other Industry Participants
Global In Vitro Fertilization Market:
By Offerings
- Devices and systems
- Culture Media and reagents
- Equipment and accessories
By Type
- Conventional IVF
- IVF with Intracytoplasmic Sperm Injection (ICSI)
By Procedure Type
- Fresh Donor
- Frozen Donor
- Fresh Non donor
- Frozen non donor
By End Users
- Hospitals and clinics
- Fertility Clinics
- Commercial labs
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1.Historic
Years: 2015 - 2021
1.2.2.Base
Year: 2022
1.2.3.Forecast
Years: 2023 - 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1.Research
Questionnaire
3.1.2.Global
Percentage Breakdown
3.1.3.Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1.Paid
Databases
3.2.2.Secondary
Sources
3.3. Market
Size Estimates
3.3.1.Top-Down
Approach
3.3.2.Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of In Vitro Fertilization Market
6. Market Synopsis: In
Vitro Fertilization Market
7. In Vitro Fertilization Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1.Product
Definition
7.1.2.Industry
Development
7.2. Market
Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3. Trends in
In Vitro Fertilization Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: In Vitro Fertilization Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on In Vitro Fertilization Market
8. Global In Vitro Fertilization Market Analysis and Forecasts, 2023
- 2031
8.1. Overview
8.1.1.Global In
Vitro Fertilization Market Revenue (US$ Mn)
8.2. Global In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Offerings
8.2.1.Devices
and systems
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2022
8.2.1.3. Market Forecast, 2023 - 2031
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2022
8.2.1.5.1.2. Market
Forecast, 2023 - 2031
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2022
8.2.1.5.2.2. Market
Forecast, 2023 - 2031
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2022
8.2.1.5.3.2. Market
Forecast, 2023 - 2031
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2022
8.2.1.5.4.2. Market
Forecast, 2023 - 2031
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2022
8.2.1.5.5.2. Market
Forecast, 2023 - 2031
8.2.2.Culture
Media and reagents
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2022
8.2.2.3. Market Forecast, 2023 - 2031
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2022
8.2.2.5.1.2. Market
Forecast, 2023 - 2031
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2022
8.2.2.5.2.2. Market
Forecast, 2023 - 2031
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2022
8.2.2.5.3.2. Market
Forecast, 2023 - 2031
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2022
8.2.2.5.4.2. Market
Forecast, 2023 - 2031
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2022
8.2.2.5.5.2. Market
Forecast, 2023 - 2031
8.2.3.Equipment and accessories
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2022
8.2.3.3. Market Forecast, 2023 - 2031
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2022
8.2.3.5.1.2. Market
Forecast, 2023 - 2031
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2022
8.2.3.5.2.2. Market
Forecast, 2023 - 2031
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2022
8.2.3.5.3.2. Market
Forecast, 2023 - 2031
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2022
8.2.3.5.4.2. Market
Forecast, 2023 - 2031
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2022
8.2.3.5.5.2. Market
Forecast, 2023 - 2031
8.3. Key
Segment for Channeling Investments
8.3.1.By
Offerings
9. Global In Vitro Fertilization Market Analysis and Forecasts, 2023
- 2031
9.1. Overview
9.2. Global In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Type
9.2.1.Conventional
IVF
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2022
9.2.1.3. Market Forecast, 2023 - 2031
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2022
9.2.1.5.1.2. Market
Forecast, 2023 - 2031
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2022
9.2.1.5.2.2. Market
Forecast, 2023 - 2031
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2022
9.2.1.5.3.2. Market
Forecast, 2023 - 2031
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2022
9.2.1.5.4.2. Market
Forecast, 2023 - 2031
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2022
9.2.1.5.5.2. Market
Forecast, 2023 - 2031
9.2.2.IVF with
Intracytoplasmic Sperm Injection (ICSI)
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2022
9.2.2.3. Market Forecast, 2023 - 2031
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2022
9.2.2.5.1.2. Market
Forecast, 2023 - 2031
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2022
9.2.2.5.2.2. Market
Forecast, 2023 - 2031
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2022
9.2.2.5.3.2. Market
Forecast, 2023 - 2031
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2022
9.2.2.5.4.2. Market
Forecast, 2023 - 2031
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2022
9.2.2.5.5.2. Market
Forecast, 2023 - 2031
9.3. Key
Segment for Channeling Investments
9.3.1.By Type
10. Global In Vitro Fertilization Market Analysis and Forecasts, 2023
- 2031
10.1. Overview
10.2. Global In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Procedure Type
10.2.1.Fresh
Donor
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 - 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 - 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 - 2031
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 - 2031
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 - 2031
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 - 2031
10.2.2.Frozen
Donor
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 - 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 - 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 - 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 - 2031
10.2.3.Fresh
Non Donor
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2022
10.2.3.3. Market Forecast, 2023 - 2031
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2022
10.2.3.5.1.2. Market
Forecast, 2023 - 2031
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2022
10.2.3.5.2.2. Market
Forecast, 2023 - 2031
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2022
10.2.3.5.3.2. Market
Forecast, 2023 - 2031
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2022
10.2.3.5.4.2. Market
Forecast, 2023 - 2031
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2022
10.2.3.5.5.2. Market
Forecast, 2023 - 2031
10.2.4.Frozen
Non Donor
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2022
10.2.4.3. Market Forecast, 2023 - 2031
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2022
10.2.4.5.1.2. Market
Forecast, 2023 - 2031
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2022
10.2.4.5.2.2. Market
Forecast, 2023 - 2031
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2022
10.2.4.5.3.2. Market
Forecast, 2023 - 2031
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2022
10.2.4.5.4.2. Market
Forecast, 2023 - 2031
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2022
10.2.4.5.5.2. Market
Forecast, 2023 - 2031
10.3. Key
Segment for Channeling Investments
10.3.1.By
Procedure Type
11. Global In Vitro Fertilization Market Analysis and Forecasts, 2023
- 2031
11.1. Overview
11.2. Global In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1.Hospitals
and Clinics
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2022
11.2.1.3. Market Forecast, 2023 - 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2022
11.2.1.5.1.2. Market
Forecast, 2023 - 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2022
11.2.1.5.2.2. Market
Forecast, 2023 - 2031
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2022
11.2.1.5.3.2. Market
Forecast, 2023 - 2031
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2022
11.2.1.5.4.2. Market
Forecast, 2023 - 2031
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2022
11.2.1.5.5.2. Market
Forecast, 2023 - 2031
11.2.2.Fertility
Clinics
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2022
11.2.2.3. Market Forecast, 2023 - 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2022
11.2.2.5.1.2. Market
Forecast, 2023 - 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2022
11.2.2.5.2.2. Market
Forecast, 2023 - 2031
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2022
11.2.2.5.3.2. Market
Forecast, 2023 - 2031
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2022
11.2.2.5.4.2. Market
Forecast, 2023 - 2031
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2022
11.2.2.5.5.2. Market
Forecast, 2023 - 2031
11.2.3.Commercial
labs
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2022
11.2.3.3. Market Forecast, 2023 - 2031
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2022
11.2.3.5.1.2. Market
Forecast, 2023 - 2031
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2022
11.2.3.5.2.2. Market
Forecast, 2023 - 2031
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2022
11.2.3.5.3.2. Market
Forecast, 2023 - 2031
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2022
11.2.3.5.4.2. Market
Forecast, 2023 - 2031
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2022
11.2.3.5.5.2. Market
Forecast, 2023 - 2031
11.2.4.Others
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2022
11.2.4.3. Market Forecast, 2023 - 2031
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2022
11.2.4.5.1.2. Market
Forecast, 2023 - 2031
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2022
11.2.4.5.2.2. Market
Forecast, 2023 - 2031
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2022
11.2.4.5.3.2. Market
Forecast, 2023 - 2031
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2022
11.2.4.5.4.2. Market
Forecast, 2023 - 2031
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2022
11.2.4.5.5.2. Market
Forecast, 2023 - 2031
11.3. Key
Segment for Channeling Investments
11.3.1.By End
Users
12. North America In Vitro Fertilization Market Analysis and
Forecasts, 2023 - 2031
12.1. Overview
12.1.1.North
America In Vitro Fertilization Market Revenue (US$ Mn)
12.2. North
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Offerings
12.2.1.Devices
and systems
12.2.2.Culture
Media and reagents
12.2.3.Equipment and accessories
12.3. North
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Type
12.3.1.Conventional
IVF
12.3.2.IVF with
Intracytoplasmic Sperm Injection (ICSI)
12.4. North
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
12.4.1.Fresh
Donor
12.4.2.Frozen
Donor
12.4.3.Fresh
Non Donor
12.4.4.Frozen
Non Donor
12.5. North
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Users
12.5.1.Hospitals
and Clinics
12.5.2.Fertility
Clinics
12.5.3.Commercial
labs
12.5.4.Others
12.6. North
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1.U.S
12.6.1.1. U.S In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.6.1.1.1. Devices and systems
12.6.1.1.2. Culture Media and reagents
12.6.1.1.3. Equipment and
accessories
12.6.1.2. U.S In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.1.2.1. Conventional IVF
12.6.1.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
12.6.1.3. U.S In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
12.6.1.3.1. Fresh Donor
12.6.1.3.2. Frozen Donor
12.6.1.3.3. Fresh Non Donor
12.6.1.3.4. Frozen Non Donor
12.6.1.4. U.S In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
12.6.1.4.1. Hospitals and Clinics
12.6.1.4.2. Fertility Clinics
12.6.1.4.3. Commercial labs
12.6.1.4.4. Others
12.6.2.Canada
12.6.2.1. Canada In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.6.2.1.1. Devices and systems
12.6.2.1.2. Culture Media and reagents
12.6.2.1.3. Equipment and accessories
12.6.2.2. Canada In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.2.2.1. Conventional IVF
12.6.2.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
12.6.2.3. Canada In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
12.6.2.3.1. Fresh Donor
12.6.2.3.2. Frozen Donor
12.6.2.3.3. Fresh Non Donor
12.6.2.3.4. Frozen Non Donor
12.6.2.4. Canada In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
12.6.2.4.1. Hospitals and Clinics
12.6.2.4.2. Fertility Clinics
12.6.2.4.3. Commercial labs
12.6.2.4.4. Others
12.6.3.Mexico
12.6.3.1. Mexico In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts,
By Offerings
12.6.3.1.1. Devices and systems
12.6.3.1.2. Culture Media and reagents
12.6.3.1.3. Equipment and
accessories
12.6.3.2. Mexico In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.3.2.1. Conventional IVF
12.6.3.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
12.6.3.3. Mexico In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
12.6.3.3.1. Fresh Donor
12.6.3.3.2. Frozen Donor
12.6.3.3.3. Fresh Non Donor
12.6.3.3.4. Frozen Non Donor
12.6.3.4. Mexico In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
12.6.3.4.1. Hospitals and Clinics
12.6.3.4.2. Fertility Clinics
12.6.3.4.3. Commercial labs
12.6.3.4.4. Others
12.6.4.Rest of
North America
12.6.4.1. Rest of North America In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Offerings
12.6.4.1.1. Devices and systems
12.6.4.1.2. Culture Media and reagents
12.6.4.1.3. Equipment and
accessories
12.6.4.2. Rest of North America In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Type
12.6.4.2.1. Conventional IVF
12.6.4.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
12.6.4.3. Rest of North America In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Procedure Type
12.6.4.3.1. Fresh Donor
12.6.4.3.2. Frozen Donor
12.6.4.3.3. Fresh Non Donor
12.6.4.3.4. Frozen Non Donor
12.6.4.4. Rest of North America In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By End Users
12.6.4.4.1. Hospitals and Clinics
12.6.4.4.2. Fertility Clinics
12.6.4.4.3. Commercial labs
12.6.4.4.4. Others
12.7. Key
Segment for Channeling Investments
12.7.1.By
Country
12.7.2.By
Offerings
12.7.3.By Type
12.7.4.By
Procedure Type
12.7.5.By End
Users
13. Europe In Vitro Fertilization Market Analysis and Forecasts, 2023
- 2031
13.1. Overview
13.1.1.Europe
In Vitro Fertilization Market Revenue (US$ Mn)
13.2. Europe In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Offerings
13.2.1.Devices
and systems
13.2.2.Culture
Media and reagents
13.2.3.Equipment and accessories
13.3. Europe In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Type
13.3.1.Conventional
IVF
13.3.2.IVF with
Intracytoplasmic Sperm Injection (ICSI)
13.4. Europe In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.4.1.Fresh
Donor
13.4.2.Frozen
Donor
13.4.3.Fresh
Non Donor
13.4.4.Frozen
Non Donor
13.5. Europe In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1.Hospitals
and Clinics
13.5.2.Fertility
Clinics
13.5.3.Commercial
labs
13.5.4.Others
13.6. Europe In
Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1.France
13.6.1.1. France In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.1.1.1. Devices and systems
13.6.1.1.2. Culture Media and reagents
13.6.1.1.3. Equipment and
accessories
13.6.1.2. France In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.1.2.1. Conventional IVF
13.6.1.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
13.6.1.3. France In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.1.3.1. Fresh Donor
13.6.1.3.2. Frozen Donor
13.6.1.3.3. Fresh Non Donor
13.6.1.3.4. Frozen Non Donor
13.6.1.4. France In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.1.4.1. Hospitals and Clinics
13.6.1.4.2. Fertility Clinics
13.6.1.4.3. Commercial labs
13.6.1.4.4. Others
13.6.2.The UK
13.6.2.1. The UK In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts,
By Offerings
13.6.2.1.1. Devices and systems
13.6.2.1.2. Culture Media and reagents
13.6.2.1.3. Equipment and
accessories
13.6.2.2. The UK In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.2.2.1. Conventional IVF
13.6.2.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
13.6.2.3. The UK In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.2.3.1. Fresh Donor
13.6.2.3.2. Frozen Donor
13.6.2.3.3. Fresh Non Donor
13.6.2.3.4. Frozen Non Donor
13.6.2.4. The UK In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.2.4.1. Hospitals and Clinics
13.6.2.4.2. Fertility Clinics
13.6.2.4.3. Commercial labs
13.6.2.4.4. Others
13.6.3.Spain
13.6.3.1. Spain In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.3.1.1. Devices and systems
13.6.3.1.2. Culture Media and reagents
13.6.3.1.3. Equipment and
accessories
13.6.3.2. Spain In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.3.2.1. Conventional IVF
13.6.3.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
13.6.3.3. Spain In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.3.3.1. Fresh Donor
13.6.3.3.2. Frozen Donor
13.6.3.3.3. Fresh Non Donor
13.6.3.3.4. Frozen Non Donor
13.6.3.4. Spain In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.3.4.1. Hospitals and Clinics
13.6.3.4.2. Fertility Clinics
13.6.3.4.3. Commercial labs
13.6.3.4.4. Others
13.6.4.Germany
13.6.4.1. Germany In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.4.1.1. Devices and systems
13.6.4.1.2. Culture Media and reagents
13.6.4.1.3. Equipment and
accessories
13.6.4.2. Germany In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.4.2.1. Conventional IVF
13.6.4.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
13.6.4.3. Germany In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.4.3.1. Fresh Donor
13.6.4.3.2. Frozen Donor
13.6.4.3.3. Fresh Non Donor
13.6.4.3.4. Frozen Non Donor
13.6.4.4. Germany In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.4.4.1. Hospitals and Clinics
13.6.4.4.2. Fertility Clinics
13.6.4.4.3. Commercial labs
13.6.4.4.4. Others
13.6.5.Italy
13.6.5.1. Italy In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.5.1.1. Devices and systems
13.6.5.1.2. Culture Media and reagents
13.6.5.1.3. Equipment and
accessories
13.6.5.2. Italy In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.5.2.1. Conventional IVF
13.6.5.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
13.6.5.3. Italy In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.5.3.1. Fresh Donor
13.6.5.3.2. Frozen Donor
13.6.5.3.3. Fresh Non Donor
13.6.5.3.4. Frozen Non Donor
13.6.5.4. Italy In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.5.4.1. Hospitals and Clinics
13.6.5.4.2. Fertility Clinics
13.6.5.4.3. Commercial labs
13.6.5.4.4. Others
13.6.6.Nordic
Countries
13.6.6.1. Nordic Countries In Vitro Fertilization Market Revenue (US$
Mn) and Forecasts, By Offerings
13.6.6.1.1. Devices and systems
13.6.6.1.2. Culture Media and reagents
13.6.6.1.3. Equipment and
accessories
13.6.6.2. Nordic Countries In Vitro Fertilization Market Revenue (US$
Mn) and Forecasts, By Type
13.6.6.2.1. Conventional IVF
13.6.6.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
13.6.6.3. Nordic Countries In Vitro Fertilization Market Revenue (US$
Mn) and Forecasts, By Procedure Type
13.6.6.3.1. Fresh Donor
13.6.6.3.2. Frozen Donor
13.6.6.3.3. Fresh Non Donor
13.6.6.3.4. Frozen Non Donor
13.6.6.4. Nordic Countries In Vitro Fertilization Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.6.4.1. Hospitals and Clinics
13.6.6.4.2. Fertility Clinics
13.6.6.4.3. Commercial labs
13.6.6.4.4. Others
13.6.6.5. Nordic Countries In Vitro Fertilization Market Revenue (US$
Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7.Benelux
Union
13.6.7.1. Benelux Union In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Offerings
13.6.7.1.1. Devices and systems
13.6.7.1.2. Culture Media and reagents
13.6.7.1.3. Equipment and
accessories
13.6.7.2. Benelux Union In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Type
13.6.7.2.1. Conventional IVF
13.6.7.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
13.6.7.3. Benelux Union In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Procedure Type
13.6.7.3.1. Fresh Donor
13.6.7.3.2. Frozen Donor
13.6.7.3.3. Fresh Non Donor
13.6.7.3.4. Frozen Non Donor
13.6.7.4. Benelux Union In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By End Users
13.6.7.4.1. Hospitals and Clinics
13.6.7.4.2. Fertility Clinics
13.6.7.4.3. Commercial labs
13.6.7.4.4. Others
13.6.7.5. Benelux Union In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8.Rest of
Europe
13.6.8.1. Rest of Europe In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Offerings
13.6.8.1.1. Devices and systems
13.6.8.1.2. Culture Media and reagents
13.6.8.1.3. Equipment and
accessories
13.6.8.2. Rest of Europe In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Type
13.6.8.2.1. Conventional IVF
13.6.8.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
13.6.8.3. Rest of Europe In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Procedure Type
13.6.8.3.1. Fresh Donor
13.6.8.3.2. Frozen Donor
13.6.8.3.3. Fresh Non Donor
13.6.8.3.4. Frozen Non Donor
13.6.8.4. Rest of Europe In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By End Users
13.6.8.4.1. Hospitals and Clinics
13.6.8.4.2. Fertility Clinics
13.6.8.4.3. Commercial labs
13.6.8.4.4. Others
13.7. Key
Segment for Channeling Investments
13.7.1.By
Country
13.7.2.By
Offerings
13.7.3.By Type
13.7.4.By
Procedure Type
13.7.5.By End
Users
14. Asia Pacific In Vitro Fertilization Market Analysis and
Forecasts, 2023 - 2031
14.1. Overview
14.1.1.Asia
Pacific In Vitro Fertilization Market Revenue (US$ Mn)
14.2. Asia
Pacific In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Offerings
14.2.1.Devices
and systems
14.2.2.Culture
Media and reagents
14.2.3.Equipment and accessories
14.3. Asia
Pacific In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Type
14.3.1.Conventional
IVF
14.3.2.IVF with
Intracytoplasmic Sperm Injection (ICSI)
14.4. Asia Pacific
In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Procedure Type
14.4.1.Fresh
Donor
14.4.2.Frozen
Donor
14.4.3.Fresh
Non Donor
14.4.4.Frozen
Non Donor
14.5. Asia
Pacific In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Users
14.5.1.Hospitals
and Clinics
14.5.2.Fertility
Clinics
14.5.3.Commercial
labs
14.5.4.Others
14.6. Asia
Pacific In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1.China
14.6.1.1. China In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.1.1.1. Devices and systems
14.6.1.1.2. Culture Media and reagents
14.6.1.1.3. Equipment and
accessories
14.6.1.2. China In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.1.2.1. Conventional IVF
14.6.1.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
14.6.1.3. China In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.1.3.1. Fresh Donor
14.6.1.3.2. Frozen Donor
14.6.1.3.3. Fresh Non Donor
14.6.1.3.4. Frozen Non Donor
14.6.1.4. China In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.1.4.1. Hospitals and Clinics
14.6.1.4.2. Fertility Clinics
14.6.1.4.3. Commercial labs
14.6.1.4.4. Others
14.6.2.Japan
14.6.2.1. Japan In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.2.1.1. Devices and systems
14.6.2.1.2. Culture Media and reagents
14.6.2.1.3. Equipment and
accessories
14.6.2.2. Japan In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.2.2.1. Conventional IVF
14.6.2.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
14.6.2.3. Japan In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.2.3.1. Fresh Donor
14.6.2.3.2. Frozen Donor
14.6.2.3.3. Fresh Non Donor
14.6.2.3.4. Frozen Non Donor
14.6.2.4. Japan In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.2.4.1. Hospitals and Clinics
14.6.2.4.2. Fertility Clinics
14.6.2.4.3. Commercial labs
14.6.2.4.4. Others
14.6.3.India
14.6.3.1. India In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.3.1.1. Devices and systems
14.6.3.1.2. Culture Media and reagents
14.6.3.1.3. Equipment and
accessories
14.6.3.2. India In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.3.2.1. Conventional IVF
14.6.3.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
14.6.3.3. India In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.3.3.1. Fresh Donor
14.6.3.3.2. Frozen Donor
14.6.3.3.3. Fresh Non Donor
14.6.3.3.4. Frozen Non Donor
14.6.3.4. India In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.3.4.1. Hospitals and Clinics
14.6.3.4.2. Fertility Clinics
14.6.3.4.3. Commercial labs
14.6.3.4.4. Others
14.6.4.New
Zealand
14.6.4.1. New Zealand In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.4.1.1. Devices and systems
14.6.4.1.2. Culture Media and reagents
14.6.4.1.3. Equipment and
accessories
14.6.4.2. New Zealand In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.4.2.1. Conventional IVF
14.6.4.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
14.6.4.3. New Zealand In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.4.3.1. Fresh Donor
14.6.4.3.2. Frozen Donor
14.6.4.3.3. Fresh Non Donor
14.6.4.3.4. Frozen Non Donor
14.6.4.4. New Zealand In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.4.4.1. Hospitals and Clinics
14.6.4.4.2. Fertility Clinics
14.6.4.4.3. Commercial labs
14.6.4.4.4. Others
14.6.5.Australia
14.6.5.1. Australia In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.5.1.1. Devices and systems
14.6.5.1.2. Culture Media and reagents
14.6.5.1.3. Equipment and
accessories
14.6.5.2. Australia In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.5.2.1. Conventional IVF
14.6.5.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
14.6.5.3. Australia In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.5.3.1. Fresh Donor
14.6.5.3.2. Frozen Donor
14.6.5.3.3. Fresh Non Donor
14.6.5.3.4. Frozen Non Donor
14.6.5.4. Australia In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.5.4.1. Hospitals and Clinics
14.6.5.4.2. Fertility Clinics
14.6.5.4.3. Commercial labs
14.6.5.4.4. Others
14.6.6.South
Korea
14.6.6.1. South Korea In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.6.1.1. Devices and systems
14.6.6.1.2. Culture Media and reagents
14.6.6.1.3. Equipment and
accessories
14.6.6.2. South Korea In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.6.2.1. Conventional IVF
14.6.6.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
14.6.6.3. South Korea In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.6.3.1. Fresh Donor
14.6.6.3.2. Frozen Donor
14.6.6.3.3. Fresh Non Donor
14.6.6.3.4. Frozen Non Donor
14.6.6.4. South Korea In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.6.4.1. Hospitals and Clinics
14.6.6.4.2. Fertility Clinics
14.6.6.4.3. Commercial labs
14.6.6.4.4. Others
14.6.7.Southeast
Asia
14.6.7.1. Southeast Asia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.6.7.1.1. Devices and systems
14.6.7.1.2. Culture Media and reagents
14.6.7.1.3. Equipment and
accessories
14.6.7.2. Southeast Asia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Type
14.6.7.2.1. Conventional IVF
14.6.7.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
14.6.7.3. Southeast Asia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Procedure Type
14.6.7.3.1. Fresh Donor
14.6.7.3.2. Frozen Donor
14.6.7.3.3. Fresh Non Donor
14.6.7.3.4. Frozen Non Donor
14.6.7.4. Southeast Asia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.7.4.1. Hospitals and Clinics
14.6.7.4.2. Fertility Clinics
14.6.7.4.3. Commercial labs
14.6.7.4.4. Others
14.6.7.5. Southeast Asia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8.Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Offerings
14.6.8.1.1. Devices and systems
14.6.8.1.2. Culture Media and reagents
14.6.8.1.3. Equipment and
accessories
14.6.8.2. Rest of Asia Pacific In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Type
14.6.8.2.1. Conventional IVF
14.6.8.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
14.6.8.3. Rest of Asia Pacific In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Procedure Type
14.6.8.3.1. Fresh Donor
14.6.8.3.2. Frozen Donor
14.6.8.3.3. Fresh Non Donor
14.6.8.3.4. Frozen Non Donor
14.6.8.4. Rest of Asia Pacific In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.8.4.1. Hospitals and Clinics
14.6.8.4.2. Fertility Clinics
14.6.8.4.3. Commercial labs
14.6.8.4.4. Others
14.7. Key
Segment for Channeling Investments
14.7.1.By
Country
14.7.2.By
Offerings
14.7.3.By Type
14.7.4.By
Procedure Type
14.7.5.By End
Users
15. Middle East and Africa In Vitro Fertilization Market Analysis
and Forecasts, 2023 - 2031
15.1. Overview
15.1.1.Middle
East and Africa In Vitro Fertilization Market Revenue (US$ Mn)
15.2. Middle
East and Africa In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts,
By Offerings
15.2.1.Devices
and systems
15.2.2.Culture
Media and reagents
15.2.3.Equipment and accessories
15.3. Middle
East and Africa In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts,
By Type
15.3.1.Conventional
IVF
15.3.2.IVF with
Intracytoplasmic Sperm Injection (ICSI)
15.4. Middle
East and Africa In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
15.4.1.Fresh
Donor
15.4.2.Frozen
Donor
15.4.3.Fresh
Non Donor
15.4.4.Frozen
Non Donor
15.5. Middle
East and Africa In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts,
By End Users
15.5.1.Hospitals
and Clinics
15.5.2.Fertility
Clinics
15.5.3.Commercial
labs
15.5.4.Others
15.6. Middle
East and Africa In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts,
By Country
15.6.1.Saudi
Arabia
15.6.1.1. Saudi Arabia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.6.1.1.1. Devices and systems
15.6.1.1.2. Culture Media and reagents
15.6.1.1.3. Equipment and
accessories
15.6.1.2. Saudi Arabia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Type
15.6.1.2.1. Conventional IVF
15.6.1.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
15.6.1.3. Saudi Arabia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Procedure Type
15.6.1.3.1. Fresh Donor
15.6.1.3.2. Frozen Donor
15.6.1.3.3. Fresh Non Donor
15.6.1.3.4. Frozen Non Donor
15.6.1.4. Saudi Arabia In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By End Users
15.6.1.4.1. Hospitals and Clinics
15.6.1.4.2. Fertility Clinics
15.6.1.4.3. Commercial labs
15.6.1.4.4. Others
15.6.2.UAE
15.6.2.1. UAE In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.6.2.1.1. Devices and systems
15.6.2.1.2. Culture Media and reagents
15.6.2.1.3. Equipment and
accessories
15.6.2.2. UAE In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.2.2.1. Conventional IVF
15.6.2.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
15.6.2.3. UAE In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
15.6.2.3.1. Fresh Donor
15.6.2.3.2. Frozen Donor
15.6.2.3.3. Fresh Non Donor
15.6.2.3.4. Frozen Non Donor
15.6.2.4. UAE In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.2.4.1. Hospitals and Clinics
15.6.2.4.2. Fertility Clinics
15.6.2.4.3. Commercial labs
15.6.2.4.4. Others
15.6.3.Egypt
15.6.3.1. Egypt In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.6.3.1.1. Devices and systems
15.6.3.1.2. Culture Media and reagents
15.6.3.1.3. Equipment and
accessories
15.6.3.2. Egypt In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.3.2.1. Conventional IVF
15.6.3.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
15.6.3.3. Egypt In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
15.6.3.3.1. Fresh Donor
15.6.3.3.2. Frozen Donor
15.6.3.3.3. Fresh Non Donor
15.6.3.3.4. Frozen Non Donor
15.6.3.4. Egypt In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.3.4.1. Hospitals and Clinics
15.6.3.4.2. Fertility Clinics
15.6.3.4.3. Commercial labs
15.6.3.4.4. Others
15.6.4.Kuwait
15.6.4.1. Kuwait In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.6.4.1.1. Devices and systems
15.6.4.1.2. Culture Media and reagents
15.6.4.1.3. Equipment and
accessories
15.6.4.2. Kuwait In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.4.2.1. Conventional IVF
15.6.4.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
15.6.4.3. Kuwait In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
15.6.4.3.1. Fresh Donor
15.6.4.3.2. Frozen Donor
15.6.4.3.3. Fresh Non Donor
15.6.4.3.4. Frozen Non Donor
15.6.4.4. Kuwait In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.4.4.1. Hospitals and Clinics
15.6.4.4.2. Fertility Clinics
15.6.4.4.3. Commercial labs
15.6.4.4.4. Others
15.6.5.South
Africa
15.6.5.1. South Africa In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.6.5.1.1. Devices and systems
15.6.5.1.2. Culture Media and reagents
15.6.5.1.3. Equipment and
accessories
15.6.5.2. South Africa In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Type
15.6.5.2.1. Conventional IVF
15.6.5.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
15.6.5.3. South Africa In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By Procedure Type
15.6.5.3.1. Fresh Donor
15.6.5.3.2. Frozen Donor
15.6.5.3.3. Fresh Non Donor
15.6.5.3.4. Frozen Non Donor
15.6.5.4. South Africa In Vitro Fertilization Market Revenue (US$ Mn)
and Forecasts, By End Users
15.6.5.4.1. Hospitals and Clinics
15.6.5.4.2. Fertility Clinics
15.6.5.4.3. Commercial labs
15.6.5.4.4. Others
15.6.6.Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa In Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Offerings
15.6.6.1.1. Devices and systems
15.6.6.1.2. Culture Media and reagents
15.6.6.1.3. Equipment and
accessories
15.6.6.2. Rest of Middle East & Africa In Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Type
15.6.6.2.1. Conventional IVF
15.6.6.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
15.6.6.3. Rest of Middle East & Africa In Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Procedure Type
15.6.6.3.1. Fresh Donor
15.6.6.3.2. Frozen Donor
15.6.6.3.3. Fresh Non Donor
15.6.6.3.4. Frozen Non Donor
15.6.6.4. Rest of Middle East & Africa In Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Hospitals and Clinics
15.6.6.4.2. Fertility Clinics
15.6.6.4.3. Commercial labs
15.6.6.4.4. Others
15.7. Key
Segment for Channeling Investments
15.7.1.By
Country
15.7.2.By
Offerings
15.7.3.By Type
15.7.4.By
Procedure Type
15.7.5.By End
Users
16. Latin America In Vitro Fertilization Market Analysis and
Forecasts, 2023 - 2031
16.1. Overview
16.1.1.Latin
America In Vitro Fertilization Market Revenue (US$ Mn)
16.2. Latin
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Offerings
16.2.1.Devices
and systems
16.2.2.Culture
Media and reagents
16.2.3.Equipment and accessories
16.3. Latin
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Type
16.3.1.Conventional
IVF
16.3.2.IVF with
Intracytoplasmic Sperm Injection (ICSI)
16.4. Latin
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
16.4.1.Fresh
Donor
16.4.2.Frozen
Donor
16.4.3.Fresh
Non Donor
16.4.4.Frozen
Non Donor
16.5. Latin
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Users
16.5.1.Hospitals
and Clinics
16.5.2.Fertility
Clinics
16.5.3.Commercial
labs
16.5.4.Others
16.6. Latin
America In Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Country
16.6.1.Brazil
16.6.1.1. Brazil In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.6.1.1.1. Devices and systems
16.6.1.1.2. Culture Media and reagents
16.6.1.1.3. Equipment and
accessories
16.6.1.2. Brazil In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
16.6.1.2.1. Conventional IVF
16.6.1.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
16.6.1.3. Brazil In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
16.6.1.3.1. Fresh Donor
16.6.1.3.2. Frozen Donor
16.6.1.3.3. Fresh Non Donor
16.6.1.3.4. Frozen Non Donor
16.6.1.4. Brazil In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.1.4.1. Hospitals and Clinics
16.6.1.4.2. Fertility Clinics
16.6.1.4.3. Commercial labs
16.6.1.4.4. Others
16.6.2.Argentina
16.6.2.1. Argentina In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.6.2.1.1. Devices and systems
16.6.2.1.2. Culture Media and reagents
16.6.2.1.3. Equipment and
accessories
16.6.2.2. Argentina In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Type
16.6.2.2.1. Conventional IVF
16.6.2.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
16.6.2.3. Argentina In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
16.6.2.3.1. Fresh Donor
16.6.2.3.2. Frozen Donor
16.6.2.3.3. Fresh Non Donor
16.6.2.3.4. Frozen Non Donor
16.6.2.4. Argentina In Vitro Fertilization Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.2.4.1. Hospitals and Clinics
16.6.2.4.2. Fertility Clinics
16.6.2.4.3. Commercial labs
16.6.2.4.4. Others
16.6.3.Rest of
Latin America
16.6.3.1. Rest of Latin America In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Offerings
16.6.3.1.1. Devices and systems
16.6.3.1.2. Culture Media and reagents
16.6.3.1.3. Equipment and
accessories
16.6.3.2. Rest of Latin America In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Type
16.6.3.2.1. Conventional IVF
16.6.3.2.2. IVF with Intracytoplasmic Sperm Injection (ICSI)
16.6.3.3. Rest of Latin America In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Procedure Type
16.6.3.3.1. Fresh Donor
16.6.3.3.2. Frozen Donor
16.6.3.3.3. Fresh Non Donor
16.6.3.3.4. Frozen Non Donor
16.6.3.4. Rest of Latin America In Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By End Users
16.6.3.4.1. Hospitals and Clinics
16.6.3.4.2. Fertility Clinics
16.6.3.4.3. Commercial labs
16.6.3.4.4. Others
16.7. Key
Segment for Channeling Investments
16.7.1.By
Country
16.7.2.By
Offerings
16.7.3.By Type
16.7.4.By Procedure
Type
16.7.5.By End
Users
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2022
17.3. Global
Presence and Growth Strategies
17.3.1.Mergers
and Acquisitions
17.3.2.Product
Launches
17.3.3.Investments
Trends
17.3.4.R&D
Initiatives
18. Player Profiles
18.1. A
CooperSurgical Fertility Company
18.1.1.Company
Details
18.1.2.Company
Overview
18.1.3.Product
Offerings
18.1.4.Key
Developments
18.1.5.Financial
Analysis
18.1.6.SWOT
Analysis
18.1.7.Business
Strategies
18.2. Boston IVF
18.2.1.Company
Details
18.2.2.Company
Overview
18.2.3.Product
Offerings
18.2.4.Key
Developments
18.2.5.Financial
Analysis
18.2.6.SWOT
Analysis
18.2.7.Business
Strategies
18.3. Cook
18.3.1.Company
Details
18.3.2.Company
Overview
18.3.3.Product
Offerings
18.3.4.Key
Developments
18.3.5.Financial
Analysis
18.3.6.SWOT
Analysis
18.3.7.Business
Strategies
18.4. Esco Micro Pte. Ltd.
18.4.1.Company
Details
18.4.2.Company
Overview
18.4.3.Product
Offerings
18.4.4.Key
Developments
18.4.5.Financial
Analysis
18.4.6.SWOT
Analysis
18.4.7.Business
Strategies
18.5. Fujifilm Irvine Scientific
18.5.1.Company
Details
18.5.2.Company
Overview
18.5.3.Product
Offerings
18.5.4.Key
Developments
18.5.5.Financial
Analysis
18.5.6.SWOT
Analysis
18.5.7.Business
Strategies
18.6. Genea Biomedx
18.6.1.Company
Details
18.6.2.Company
Overview
18.6.3.Product
Offerings
18.6.4.Key Developments
18.6.5.Financial
Analysis
18.6.6.SWOT
Analysis
18.6.7.Business
Strategies
18.7. IVFtech ApS
18.7.1.Company
Details
18.7.2.Company
Overview
18.7.3.Product
Offerings
18.7.4.Key
Developments
18.7.5.Financial
Analysis
18.7.6.SWOT
Analysis
18.7.7.Business
Strategies
18.8. Kitazato Corporation
18.8.1.Company
Details
18.8.2.Company
Overview
18.8.3.Product
Offerings
18.8.4.Key
Developments
18.8.5.Financial
Analysis
18.8.6.SWOT
Analysis
18.8.7.Business
Strategies
18.9. OvaScience
18.9.1.Company
Details
18.9.2.Company
Overview
18.9.3.Product
Offerings
18.9.4.Key
Developments
18.9.5.Financial
Analysis
18.9.6.SWOT
Analysis
18.9.7.Business
Strategies
18.10. Thermo Fisher Scientific
18.10.1.Company
Details
18.10.2.Company
Overview
18.10.3.Product
Offerings
18.10.4.Key
Developments
18.10.5.Financial
Analysis
18.10.6.SWOT
Analysis
18.10.7.Business
Strategies
18.11. Vitrolife AB
18.11.1.Company
Details
18.11.2.Company
Overview
18.11.3.Product
Offerings
18.11.4.Key
Developments
18.11.5.Financial
Analysis
18.11.6.SWOT
Analysis
18.11.7.Business
Strategies
18.12. Other
Market Participants
19. Key Findings
Note: This
ToC is tentative and can be changed according to the research study conducted
during the course of report completion.
**Exclusive
for Multi-User and Enterprise User
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.